HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryujiro Suzuki Selected Research

3,4- dipropyl- 4,5,7,8- tetrahydro- 3H- imidazo(1,2- i)purin- 5- one

2/2002Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocyte-macrophage colony-stimulating factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryujiro Suzuki Research Topics

Disease

9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2016 - 05/2006
5Neoplasms (Cancer)
10/2015 - 01/2009
4Lung Neoplasms (Lung Cancer)
10/2014 - 01/2009
3Neoplasm Metastasis (Metastasis)
10/2015 - 01/2005
3Asthma (Bronchial Asthma)
01/2004 - 02/2002
2Adenocarcinoma of Lung
10/2015 - 09/2012
2Pneumonia (Pneumonitis)
09/2015 - 10/2013
2Disease Progression
11/2014 - 10/2014
2Dyspnea (Shortness of Breath)
10/2014 - 01/2014
2Carcinoma (Carcinomatosis)
09/2014 - 05/2014
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2012 - 01/2005
1Retinal Detachment (Retinal Detachments)
10/2015
1Communicable Diseases (Infectious Diseases)
09/2015
1Cough
10/2014
1Intestinal Perforation
09/2014
1Leukocytosis (Pleocytosis)
09/2014
1Febrile Neutropenia
06/2014
1Adenoid Cystic Carcinoma (Cylindroma)
01/2014
1Healthcare-Associated Pneumonia
10/2013
1Cardiac Tamponade
09/2012
1Pleural Effusion (Pleural Effusions)
09/2012
1Neutropenia
05/2012
1Leukopenia
05/2012
1Tuberculosis (Tuberculoses)
12/2007
1Cystic Fibrosis (Mucoviscidosis)
04/2004
1Chronic Pancreatitis
04/2004
1Chronic Obstructive Pulmonary Disease (COPD)
01/2004
1Airway Remodeling
01/2004

Drug/Important Bio-Agent (IBA)

8Carboplatin (JM8)FDA LinkGeneric
04/2016 - 05/2006
4Bevacizumab (Avastin)FDA Link
10/2015 - 09/2012
3Pemetrexed (MTA)FDA Link
04/2016 - 09/2012
3ErbB Receptors (EGF Receptor)IBA
11/2014 - 09/2012
3Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2014 - 05/2014
3Paclitaxel (Taxol)FDA LinkGeneric
09/2014 - 09/2010
2Gefitinib (Iressa)FDA Link
10/2014 - 09/2012
2Docetaxel (Taxotere)FDA Link
09/2010 - 05/2006
1PlatinumIBA
07/2016
1Anti-Bacterial Agents (Antibiotics)IBA
09/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2014
1Cefepime (Maxipime)FDA LinkGeneric
06/2014
1Pharmaceutical PreparationsIBA
10/2013
1Dihydrotachysterol (AT 10)IBA
10/2013
1amrubicinolIBA
05/2012
1amrubicinIBA
05/2012
1hydroxide ionIBA
05/2012
1GemcitabineFDA Link
12/2010
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2009
1LigandsIBA
01/2005
1Fas Ligand Protein (Fas Ligand)IBA
01/2005
1ChloridesIBA
04/2004
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
04/2004
1Peptide Hydrolases (Proteases)FDA Link
01/2004
1Matrix Metalloproteinases (MMPs)IBA
01/2004
1GlucocorticoidsIBA
12/2002
1Adrenergic Receptors (Adrenergic Receptor)IBA
12/2002
1tulobuterolIBA
12/2002
1Theophylline (Theon)FDA LinkGeneric
02/2002
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2002
1Phosphodiesterase 4 InhibitorsIBA
02/2002
1RolipramIBA
02/2002
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
02/2002
13,4- dipropyl- 4,5,7,8- tetrahydro- 3H- imidazo(1,2- i)purin- 5- oneIBA
02/2002

Therapy/Procedure

8Drug Therapy (Chemotherapy)
07/2016 - 01/2005
6Therapeutics
10/2014 - 12/2002
2Radiotherapy
10/2015 - 06/2014
2Maintenance Chemotherapy
05/2014 - 09/2012
1Intravitreal Injections
10/2015
1Combination Drug Therapy (Combination Chemotherapy)
09/2014
1Argon Plasma Coagulation
01/2014
1Palliative Care (Palliative Therapy)
01/2014
1Adjuvant Chemotherapy
12/2010